Ind Swift Laboratories Share Price

Ind Swift Laboratories Share Price

NSE: INDSWFTLAB
|
Pharmaceuticals
|
S Cap
₹ 405.05
-₹0.50 (-0.12%)
1D
Last updated 23 Sep, 2026, 15:59 IST

Ind Swift Laboratories Share Price Today

As of 23 Sep 2026, Ind Swift Laboratories share price is ₹405.05. The stock opened at ₹409.00, compared to its previous close of ₹405.55. During today's trading session, Ind Swift Laboratories share price moved in the range of ₹391.95 to ₹412.00, with an average price of ₹401.98 for the day. Looking at its last 52-week, the stock has touched a low of ₹87.15 and a high of ₹417.00. On the performance front, Ind Swift Laboratories share price has increased by 186.59% over the last six months and is up 288.68% on a year-on-year basis.

₹391.95
0.12% down today
₹412.00
1D LOW
1D HIGH

Ind Swift Laboratories Returns Calculator

Circuit
L
H
₹324.45
₹486.65
52-week
L
H
₹87.15
₹417.00

About Ind Swift Laboratories

Ind Swift Laboratories Share Price
ISIN
INE915B01019
Sector Market Cap
₹ 3,529.77 Cr

Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.

Ind Swift Laboratories Financial Highlights

  • Revenue: Ind Swift Laboratories reported revenue of ₹688.26 crore in FY26 vs ₹643.09 crore in FY25. It showed an increase of 7.02% on a yearly basis.
  • Operating Profit: Ind Swift Laboratories reported an operating profit of ₹49.05 crore in FY26 vs ₹257.80 crore in FY25. It showed a decrease of 80.97% on a year-on-year basis.
  • Net Profit: Ind Swift Laboratories reported a net profit of ₹41.32 crore in FY26 vs ₹250.53 crore in FY25. It showed a decrease of 83.51% on a yearly basis.

Ind Swift Laboratories Quarterly Result Highlights

  • Ind Swift Laboratories reported revenue of ₹199.10 crore in Jun 2026, compared with ₹172.01 crore in Mar 2026, representing an increase of 15.75% on a quarter-on-quarter (QoQ) basis.
  • Ind Swift Laboratories reported an operating profit of ₹32.56 crore in Jun 2026, compared with ₹11.96 crore in Mar 2026, representing an increase of 172.24% on a quarter-on-quarter (QoQ) basis.
  • Ind Swift Laboratories reported a profit of ₹24.57 crore in Jun 2026, compared with ₹15.11 crore in Mar 2026, reflecting an increase of 62.61% on a QoQ basis.
  • The earnings per share (EPS) of Ind Swift Laboratories stood at ₹37.25 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
42.93%
FII
10.70%
Other DII
0.17%
Retail and other
46.20%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202514.33%
Feb 202613.80%
Mar 202613.88%
Jun 202610.70%
Mkt Cap Cr
3,529.77
P/E
61.59
P/B
2.55
ROE
3.57%
D/E
0.01
ROCE
4.36%
Div. Yield
0.00%
EPS(TTM)
5.09
Turnover
0.40
EV/EBITDA
27.84
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.42%
Quick Ratio
0.00
Curr. Ratio
3.60
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Ind-Swift Labs. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Ind-Swift Labs. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Ind-Swift Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Ind Swift Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹561.71₹1,280.90₹1,207.31₹1,038.73
Other Income₹81.38₹45.37₹33.50₹43.50
Total Revenue₹643.09₹1,326.27₹1,240.81₹1,082.23
Total Expenses₹608.50₹1,131.10₹1,127.64₹1,069.70
Profit Before Tax₹257.80₹581.76₹86.52₹12.53
Tax₹7.27₹160.31₹38.69₹14.68
Profit After Tax₹250.53₹421.45₹47.83-₹2.15
EPS - Basic₹37.25₹71.24₹8.10-₹0.36
EPS - Diluted₹35.21₹71.24₹8.10-₹0.36

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹34.59₹195.17₹113.17₹12.53
Income before WC changes-₹5.72₹319.93₹245.95₹238.19
Change in Assets₹47.29-₹515.89-₹68.39-₹119.60
Change in Liabilities-₹67.05₹32.84₹17.07₹31.68
Change in WC-₹19.76-₹483.05-₹51.33-₹87.92
Cash flow from Operations-₹25.47-₹163.12₹194.62₹150.27
Cash flow from Investing-₹109.62-₹104.32-₹13.37₹4.77
Cash flow from Financing₹69.20₹698.91-₹185.66-₹140.88
Total Cash Flow-₹65.89₹431.48-₹4.41₹14.17
Cash (Start of the year)₹493.93₹18.20₹21.48₹11.60
Cash (End of the year)₹427.46₹449.68₹17.07₹25.77

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹572.99₹503.98₹659.55₹725.46
Current Assets₹865.35₹661.13₹1,164.52₹1,075.33
Total Assets₹1,438.34₹1,165.11₹1,824.06₹1,800.79
Current Liabilities₹220.58₹221.28₹371.09₹334.47
Net Current Asset₹644.77₹439.85₹793.43₹740.87
Non-Current Liabilities₹44.79₹12.39₹771.04₹865.47
Equity Capital₹1,172.96₹931.44₹681.93₹600.86
Total Equity & Liabilities₹1,438.34₹1,165.11₹1,824.06₹1,800.79

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹549.65₹1,672.57₹1,151.96₹988.09
Other Income₹81.27₹88.30₹33.28₹42.50
Total Revenue₹630.92₹1,760.86₹1,185.24₹1,030.59
Total Expenses₹589.98₹1,557.92₹1,079.39₹1,020.90
Profit Before Tax₹264.14₹593.93₹79.20₹8.00
Tax₹8.06₹57.76₹36.73₹13.70
Profit After Tax₹256.09₹536.18₹42.47-₹5.71
EPS - Basic₹38.08₹90.74₹7.19-₹0.97
EPS - Diluted₹36.00₹90.74₹7.19-₹0.97

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹40.94₹202.94₹105.85₹9.69
Income before WC changes₹0.67₹378.03₹238.62₹235.28
Change in Assets-₹4.90-₹526.27-₹73.90-₹134.77
Change in Liabilities-₹34.93-₹17.50₹17.95₹35.75
Change in WC-₹39.83-₹543.77-₹55.95-₹99.02
Cash flow from Operations-₹39.15-₹165.74₹182.67₹136.26
Cash flow from Investing-₹109.67-₹27.71-₹13.69₹2.76
Cash flow from Financing₹74.22₹657.78-₹168.41-₹139.59
Total Cash Flow-₹74.60₹464.33₹0.58-₹0.57
Cash (Start of the year)₹487.62₹23.28₹9.38₹9.95
Cash (End of the year)₹413.01₹487.62₹9.96₹9.38

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹628.32₹556.24₹714.20₹804.75
Current Assets₹793.73₹852.16₹1,074.07₹998.16
Total Assets₹1,422.05₹1,408.40₹1,788.27₹1,802.91
Current Liabilities₹216.35₹397.71₹350.05₹313.61
Net Current Asset₹577.38₹454.46₹724.02₹684.55
Non-Current Liabilities₹41.63₹212.55₹762.88₹856.75
Equity Capital₹1,164.08₹798.15₹675.35₹632.56
Total Equity & Liabilities₹1,422.05₹1,408.40₹1,788.27₹1,802.91
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
405.05
1510
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1510
Buy orders: 0%
Sell orders: 100%
Bearish
3
Neutral
4
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
68.91
Neutral
ATR (14)
23.84
Neutral
STOCH(9,6)
88.17
Bearish
STOCH RSI (14)
62.16
Neutral
ADX(9)
40.92
Bearish
UO(9)
58.15
Neutral
ROC(12)
8.81
Bullish
WillR(14)
-11.83
Bearish
Period
Simple value
Exponential vaue
5D
380.07
386.12
10D
381.88
379.79
20D
371.44
364.72
50D
303.84
315.29
100D
235.72
261
Volume trend — traded volume by day
23 Sep8L
22 Sep20L
21 Sep7L
18 Sep3L
17 Sep5L
16 Sep16L
Average10L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Ind Swift Laboratories Share Price
Ind Swift Laboratories
Pharmaceuticals
Add Stock
Add Another

Ind Swift Laboratories Share Price FAQs

Ind Swift Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837